David S Milstone1, Motoi Ilyama2, Mian Chen2, Peter O'Donnell2, Vannessa M Davis2, Jorge Plutzky2, Jonathan D Brown2, Saptarsi M Haldar2, Allan Siu2, Andrew C Lau2, Su-Ning Zhu2, Mayada F Basheer2, Tucker Collins2, Jenny Jongstra-Bilen2, Myron I Cybulsky1. 1. From the Vascular Research Division, Department of Pathology, Center for Excellence in Vascular Biology (D.S.M., P.O.D., V.M.D., T.C.) and Cardiovascular Division (J.P., J.D.B.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Advanced Diagnostics Division, Toronto General Research Institute, University Health Network Toronto, Ontario, Canada (M.I., M.C., A.S., A.C.L., S.-N.Z., M.F.B., J.J.-B., M.I.C.); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada (M.I., M.C., A.S., A.C.L., S.-N.Z., M.F.B., J.J.-B., M.I.C.); Department of Geriatric Medicine, Kyoto University Hospital, Kyoto, Japan (M.I.); Case Cardiovascular Research Institute, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH (S.M.H.); and Department of Pathology, Children's Hospital and Harvard Medical School, Boston, MA (T.C.). myron.cybulsky@utoronto.ca milstone@rascal.med.harvard.edu. 2. From the Vascular Research Division, Department of Pathology, Center for Excellence in Vascular Biology (D.S.M., P.O.D., V.M.D., T.C.) and Cardiovascular Division (J.P., J.D.B.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Advanced Diagnostics Division, Toronto General Research Institute, University Health Network Toronto, Ontario, Canada (M.I., M.C., A.S., A.C.L., S.-N.Z., M.F.B., J.J.-B., M.I.C.); Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada (M.I., M.C., A.S., A.C.L., S.-N.Z., M.F.B., J.J.-B., M.I.C.); Department of Geriatric Medicine, Kyoto University Hospital, Kyoto, Japan (M.I.); Case Cardiovascular Research Institute, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH (S.M.H.); and Department of Pathology, Children's Hospital and Harvard Medical School, Boston, MA (T.C.).
Abstract
RATIONALE: Human and murine Vcam1 promoters contain 2 adjacent nuclear factor-κB (NF-κB)-binding elements. Both are essential for cytokine-induced transcription of transiently transfected promoter-reporter constructs. However, the relevance of these insights to regulation of the endogenous Vcam1 gene and to pathophysiological processes in vivo remained unknown. OBJECTIVE: Determine the role of the 5' NF-κB-binding element in expression of the endogenous Vcam1 gene. METHODS AND RESULTS: Homologous recombination in embryonic stem cells was used to inactivate the 5' NF-κB element in the Vcam1 promoter and alter 3 nucleotides in the 5' untranslated region to allow direct comparison of wild-type versus mutant allele RNA expression and chromatin configuration in heterozygous mice. Systemic treatment with inflammatory cytokines or endotoxin (lipopolysaccharide) induced lower expression of the mutant allele relative to wild-type by endothelial cells in the aorta, heart, and lungs. The mutant allele also showed lower endothelial expression in 2-week atherosclerotic lesions in Vcam1 heterozygous/low-density lipoprotein receptor-deficient mice fed a cholesterol-rich diet. In vivo chromatin immunoprecipitation assays of heart showed diminished lipopolysaccharide-induced association of RNA polymerase 2 and NF-κB p65 with the mutant promoter. In contrast, expression of mutant and wild-type alleles was comparable in intimal cells of wire-injured carotid artery and 4- to 12-week atherosclerotic lesions. CONCLUSIONS: This study highlights differences between in vivo and in vitro promoter analyses, and reveals a differential role for a NF-κB transcriptional response element in endothelial vascular cell adhesion molecule-1 expression induced by inflammatory cytokines or a cholesterol-rich diet versus intimal cell expression in atherosclerotic lesions and injured arteries.
RATIONALE: Human and murineVcam1 promoters contain 2 adjacent nuclear factor-κB (NF-κB)-binding elements. Both are essential for cytokine-induced transcription of transiently transfected promoter-reporter constructs. However, the relevance of these insights to regulation of the endogenous Vcam1 gene and to pathophysiological processes in vivo remained unknown. OBJECTIVE: Determine the role of the 5' NF-κB-binding element in expression of the endogenous Vcam1 gene. METHODS AND RESULTS: Homologous recombination in embryonic stem cells was used to inactivate the 5' NF-κB element in the Vcam1 promoter and alter 3 nucleotides in the 5' untranslated region to allow direct comparison of wild-type versus mutant allele RNA expression and chromatin configuration in heterozygous mice. Systemic treatment with inflammatory cytokines or endotoxin (lipopolysaccharide) induced lower expression of the mutant allele relative to wild-type by endothelial cells in the aorta, heart, and lungs. The mutant allele also showed lower endothelial expression in 2-week atherosclerotic lesions in Vcam1 heterozygous/low-density lipoprotein receptor-deficient mice fed a cholesterol-rich diet. In vivo chromatin immunoprecipitation assays of heart showed diminished lipopolysaccharide-induced association of RNA polymerase 2 and NF-κB p65 with the mutant promoter. In contrast, expression of mutant and wild-type alleles was comparable in intimal cells of wire-injured carotid artery and 4- to 12-week atherosclerotic lesions. CONCLUSIONS: This study highlights differences between in vivo and in vitro promoter analyses, and reveals a differential role for a NF-κB transcriptional response element in endothelial vascular cell adhesion molecule-1 expression induced by inflammatory cytokines or a cholesterol-rich diet versus intimal cell expression in atherosclerotic lesions and injured arteries.
Authors: Ross D Alexander; J David Barrass; Beatriz Dichtl; Martin Kos; Tomasz Obtulowicz; Marie-Cecile Robert; Michal Koper; Iwona Karkusiewicz; Luisa Mariconti; David Tollervey; Bernhard Dichtl; Joanna Kufel; Edouard Bertrand; Jean D Beggs Journal: RNA Date: 2010-10-25 Impact factor: 4.942
Authors: Jonathan D Brown; Charles Y Lin; Qiong Duan; Gabriel Griffin; Alexander Federation; Ronald M Paranal; Steven Bair; Gail Newton; Andrew Lichtman; Andrew Kung; Tianlun Yang; Hong Wang; Francis W Luscinskas; Kevin Croce; James E Bradner; Jorge Plutzky Journal: Mol Cell Date: 2014-09-25 Impact factor: 17.970
Authors: D R Manka; P Wiegman; S Din; J M Sanders; S A Green; L W Gimple; M Ragosta; E R Powers; K Ley; I J Sarembock Journal: J Vasc Res Date: 1999 Sep-Oct Impact factor: 1.934
Authors: Priti Anand; Jonathan D Brown; Charles Y Lin; Jun Qi; Rongli Zhang; Pedro Calderon Artero; M Amer Alaiti; Jace Bullard; Kareem Alazem; Kenneth B Margulies; Thomas P Cappola; Madeleine Lemieux; Jorge Plutzky; James E Bradner; Saptarsi M Haldar Journal: Cell Date: 2013-08-01 Impact factor: 41.582
Authors: Danh T Tran; Zhenxiao Tu; Ali Alawieh; Jennifer Mulligan; Scott Esckilsen; Kristen Quinn; Kamala Sundararaj; Caroline Wallace; Ryan Finnegan; Patterson Allen; Shikhar Mehrotra; Carl Atkinson; Satish N Nadig Journal: Am J Transplant Date: 2021-11-08 Impact factor: 9.369
Authors: Lori N Eidson; Qingzeng Gao; Hongyan Qu; Daniel S Kikuchi; Ana Carolina P Campos; Elizabeth A Faidley; Yu-Yo Sun; Chia-Yi Kuan; Rosana L Pagano; Bernard Lassègue; Malú G Tansey; Kathy K Griendling; Marina S Hernandes Journal: Sci Rep Date: 2021-03-10 Impact factor: 4.996